Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1650 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

US Court Resolves Sanofi-aventis Eloxatin Patent Issue

Earlier, Sanofi-Aventis has settled three lawsuits in the US over Eloxatin against some generics manufacturers namely Teva Pharmaceuticals USA, Fresenius Kabi (formerly Dabur), Sandoz, Mayne/Hospira, MN/Par and Actavis,

Intercell FY09 Revenues Up

Intercell has posted a net loss of EUR18.37m for the full year 2009, or EUR0.39 per diluted share, compared to net income of EUR17.17m, or EUR0.37 per diluted

Sareum Strengthens Scientific Advisory Board

Dr Jackson was formerly chief scientific officer at the cancer drug discovery company, Cyclacel. Prior to that, he held senior research positions at Celltech, Agouron, DuPont and Warner-Lambert.